Archived Lecture: From Genomics to Biomarkers: A New Landscape in Sickle Cell Disease
Timothy A. Johnson Medical Scholar Lecture presented by the Fralin Biomedical Research Institute at VTC and the Virginia Tech Carilion School of Medicine
Archived Lecture: From Genomics to Biomarkers: A New Landscape in Sickle Cell Disease
Date: Nov. 6, 2020
Time: 1:00 p.m. - 2:00 p.m.
Talk Abstract
Dr. Sheehan will describe her career as a physician scientist, and how her laboratory uses genomics to unravel the mechanisms of globin switching and the pharmacogenomics of hydroxyurea in SCD, in order to develop new fetal hemoglobin inducing agents to treat people with sickle cell disease. Her work has led to a clinical trial of metformin as a fetal hemoglobin inducing agent in patients with hemoglobinopathies. Dr. Sheehan has also developed rheology biomarkers for use in assessing cure in gene based therapy, and collaborates with Dr. Gang Bao to assess the safety and efficacy of CRISPR /Cas9 based gene therapy in SCD.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and the Virginia Tech Carilion School of Medicine. The Timothy A. Johnson Medical Scholar Lecture Series hosts clinician scientists who are exploring frontiers of medicine. These lectures are principally intended for Virginia Tech Carilion School of Medicine students and Virginia Tech students in Translational Biology, Medicine, and Health graduate program. Virginia Tech and Carilion Clinic faculty, staff, and students may also attend.
You May Also Be Interested In...
-
Home ItemAddictive Nicotine and Stress Induce Convergent Mechanisms That Increase Alcohol Self‐administration , home
Feb. 21, 2025, 11:00 a.m. | John Dani, Ph.D., Professor of Neurological Sciences, Chair, Department of Neuroscience, Scientific Director, UPENN, CNS Consortium, Perlman School of Medicine, University of Pennsylvania | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home ItemExploring the Functional Role of Gene Variation in Nicotine and Alcohol Abuse , home
Feb. 21, 2025, 1 p.m. | Mariella De Biasi, Ph.D., Professor, Director, Program for Cholingeric Mechanisms in Addiction, Perlman School of Medicine, University of Pennsylvania | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home ItemThe Relationship between Mitochondrial Function and Heart Failure , home
Feb. 28, 2025, 11:00 a.m. | Rong Tian, M.D., Ph.D., Professor, Department of Anesthesiology and Bioengineering, University of Washington | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home ItemSuicide by Firearm in the United States: A Collaborative Path for Prevention , home
March 6, 2025, 5:30 p.m. (Reception at 5 p.m.) | Marian Betz, M.D., M.P.H. Professor, Departments of Epidemiology and Emergency Medicine, Deputy Director, Injury & Violence Prevention Center, University of Colorado School of Public Health; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemThinking the Right Thoughts , home
March 7, 2025, 11:00 a.m. | Nathaniel Daw, Ph.D., Professor, Computational and Theoretical Neuroscience, Department of Psychology, Princeton University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research

Vivien Sheehan, M.D., Ph.D.
Associate Professor of Pediatrics, and Director of Translational Sickle Cell Disease Research at the Emory University School of Medicine